carbapenems has been researched along with l 084 in 7 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (l 084) | Trials (l 084) | Recent Studies (post-2010) (l 084) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 18 | 1 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
| Kaneko, T; Kato, N; Liu, CX; Sakata, T; Watanabe, K | 1 |
| Furuya, N; Hosoyama, T; Ishii, Y; Matsumoto, T; Miyazaki, S; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
| Abe, T; Isoda, T; Kumagai, T; Mihira, A; Nagao, Y; Sato, C; Satoh, K; Takasaki, T; Tamai, S; Ushirogochi, H; Yamamoto, S; Yamamura, I | 1 |
| Isoda, T; Kumagai, T; Nagao, Y; Tamai, S; Yamamura, I | 1 |
| Cao, W; Ke, Y; Li, F; Li, L; Shi, W; Xi, P; Xu, H; Xu, X; Zhang, J | 1 |
| Bhavnani, SM; Ganesan, H; Gupta, VK; Melnick, D; Rubino, CM; Safir, MC; Talley, AK | 1 |
7 other study(ies) available for carbapenems and l 084
| Article | Year |
|---|---|
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
Impact of a new quinolone, DU-6859a, and two oral carbapenems, CS-834 and L-084, on the rat and mouse caecal microflora.
Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Carbapenems; Cecum; Fluoroquinolones; Male; Mice; Prodrugs; Rats; Rats, Wistar | 2000 |
In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Haemophilus Infections; Haemophilus influenzae; Male; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Prodrugs; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae | 2001 |
Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Carbapenems; Esters; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Structure; Prodrugs; Rats | 2006 |
A practical and facile synthesis of azetidine derivatives for oral carbapenem, L-084.
Topics: Administration, Oral; Azetidines; Carbapenems; Drug Industry; Humans; Molecular Structure; Stereoisomerism; Thiazoles | 2006 |
Identification of related impurities in an oral pharmaceutical formulation of tebipenem pivoxil using ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
Topics: Carbapenems; Chromatography, High Pressure Liquid; Dosage Forms; Drug Contamination; Models, Molecular; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2021 |
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide.
Topics: Administration, Oral; Anti-Bacterial Agents; Carbapenems; Humans; Monobactams; Prodrugs; Pyelonephritis; Urinary Tract Infections | 2023 |